- Home
- / Curative Biosciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Curative Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$9.3 M
2024-10-29
Revenue
$328.2 K
FY, 2012
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|---|
| Revenue | 328.2K | ||||
| Cost of goods sold | 186.1K | ||||
| Gross profit | 142.1K | ||||
| Gross profit margin, % | 43.3% | ||||
| General and administrative expense | 5.6M | 518.4K | 1.7M | 1.6M | 53.2K |
| Operating expense total | 5.7M | 518.4K | 1.7M | 1.6M | 53.2K |
| EBIT | (5.5M) | (29.9M) | 3.4M | (1.7M) | (53.2K) |
| EBIT margin, % | -1682.6% | ||||
| Net Income | (5.5M) | (29.9M) | (3.4M) | (1.7M) | (53.2K) |